AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
HCW Biologics Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG0117694Z9
1.17▲ 0.05 (4.46%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.12
Day's Range
1.09 – 1.19
52-Week Range
0.25 – 5.61
Volume
77.1K
Avg Volume
599.2K
Share Statistics
Shares Outstanding
Employees
35
Exchange
XNAS
Listed
2021-07-20
Share count as of August 14, 2026

HCW Biologics Inc. Common Stock (HCWB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about HCW Biologics Inc. Common Stock (HCWB)
What is HCW Biologics Inc. Common Stock's Market Cap?
HCW Biologics Inc. Common Stock's Market Cap is $2.1M, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's Enterprise Value?
HCW Biologics Inc. Common Stock's Enterprise Value is $1.4M, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's Price / Sales?
HCW Biologics Inc. Common Stock's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's EV / Revenue?
HCW Biologics Inc. Common Stock's EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's EV / EBITDA?
HCW Biologics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's Revenue (TTM)?
HCW Biologics Inc. Common Stock's Revenue (TTM) is $6.7M, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's Net Income (TTM)?
HCW Biologics Inc. Common Stock's Net Income (TTM) is -$5.6M, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's EBITDA?
HCW Biologics Inc. Common Stock's EBITDA is -$7.2M, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's Diluted EPS (TTM)?
HCW Biologics Inc. Common Stock's Diluted EPS (TTM) is -3.04, based on as-reported figures from SEC (XBRL) filings.
What is HCW Biologics Inc. Common Stock's EBITDA Margin?
HCW Biologics Inc. Common Stock's EBITDA Margin is -106.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · HCWBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Revenue——
YoY growth+1969.7%+129080.7%——
Cost of revenues
Gross Profit
% of revenue-69.3%99.8%——
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Legal expenses, net——
Indirect tax expense——
Total operating expenses
% of revenue2266.3%50.4%——
Operating Income
% of revenue-2335.6%49.5%——
Interest expense
Non-Operating Income (Expense)——
Other Income
Net income (loss) before income taxes——
Net income (loss)
% of revenue-3849.9%53.1%——
Net income (loss) attributable to Common Stockholders and holders of Participating Securities———
Allocation of undistributed earnings to Participating Securities———
Net income (loss attributable to Common Stockholders
Net income (loss) per share, basic
Net income (loss) per share, diluted